• BlueSky AI has positioned itself at the forefront of the booming AI infrastructure market through the introduction of its flagship SkyMod modular data centers
• BSAI’s vision is to empower the AI ecosystem, enabling companies to focus on innovation while they provide the critical infrastructure needed to succeed
• By focusing on universal computing needs rather than tying itself to single AI applications, BlueSky offers an investment proposition rooted in scale and resilience

BlueSky AI (OTC: BSAI) has rapidly emerged as a key player in modular AI data center infrastructure, achieving major milestones in the past two years. The company has moved from concept to execution with its scalable SkyMod solutions, stepped up its market visibility by upgrading to the OTCID tier, and partnered with industry accelerators, marking significant progress toward becoming an essential AI player in the data center space.

BlueSky AI has positioned itself at the forefront of the booming AI infrastructure market through the introduction of its flagship SkyMod modular data centers (ibn.fm/JyaTa). Designed for rapid deployment, these prefabricated units — SkyMod One (1 MW) and SkyMod XL (1.7 MW) — address the urgent need for scalable, energy-efficient AI compute power, while integrating advanced cooling and renewable energy compatibility (ibn.fm/7oQXq).

“Artificial intelligence is fueling an extraordinary surge in compute power demands,” said BlueSky AI CEO Trent D’Ambrosio. “BluSky AI is meeting the AI compute challenges with modular, scalable, an accelerated time to market, and energy-efficient data center solutions. Our vision is to empower the AI ecosystem, enabling companies to focus on innovation while we provide the critical infrastructure they need to succeed.” D’Ambrosio emphasizes that BlueSky’s infrastructure-first model eliminates the uncertainty of investing in specific AI companies, instead offering computing capacity that underpins all AI development.

The global data center market is currently valued at an estimated $347.6 billion in 2024 (ibn.fm/J0LEb). Projections forecast industry growth at 11.2% CAGR, reaching $652 billion by 2030, creating an impressive opportunity and indicating that BlueSky’s modular approach aligns perfectly with investor and industry demand.

In addition, last month BlueSky announced a transition from the OTC Pink tier to the OTCID tier effective July 1, 2025, signaling growing financial maturity and compliance readiness (ibn.fm/ZSmAd). This upgrade follows other strategic moves including a GPU-as-a-Service launch, new infrastructure partnerships and improved financial governance. BlueSky’s engagement with IBN to lead corporate communications underscores its focus on transparency and investor relations, positioning the company for wider capital market access (ibn.fm/Ym96W).

BlueSky AI’s mission is to empower AI innovators by eliminating infrastructure bottlenecks and accelerating time-to-compute with energy-efficient, scalable solutions. By focusing on universal computing needs rather than tying itself to single AI applications, BlueSky offers an investment proposition rooted in scale and resilience. Its off-site tested and fully assembled SkyMod units are optimized for plug-and-play deployment on BlueSky-owned land or at client sites, supporting rapid expansion and simplified logistics. Built with support for renewable energy and advanced cooling, these systems are engineered for sustainability, a key differentiator in a carbon-conscious digital age.

Leadership at BlueSky AI reflects deep domain expertise. D’Ambrosio brings a diverse background in telecommunications, finance and infrastructure. CTO Julien Bedard has extensive experience in cloud systems and cybersecurity, and COO Dan Gay adds operational excellence from decades in telecom and technology deployment. This team is committed to scaling globally within North America, where demand accounts for more than 40% of the global data center market and is expected to grow at a 10.7% CAGR from 2025 to 2030.

As BlueSky transitions to the OTCID tier, its high-profile capitalization moves, and heightened visibility further reinforce its market credibility. Daily stock traction continues to grow, supported by enhanced communications strategies and deepening investor engagement.

Looking ahead, BlueSky AI is focused on expanding SkyMod deployments, finalizing key infrastructure partnerships and scaling modular data centers across AI innovation hubs. Its first strategy offers a robust framework for investors looking to participate in the AI expansion without the risk tied to individual application performance. By combining rapid deployment technology, sustainability-minded infrastructure, regulatory compliance and roadmap-based execution, BlueSky AI is establishing itself as a foundational enabler of the next-generation AI ecosystem.

For more information, visit the company’s website at BluSkyAIDataCenters.com.

NOTE TO INVESTORS: The latest news and updates relating to BSAI are available in the company’s newsroom at https://ibn.fm/BSAI

• Nutriband and Kindeva have completed commercial-scale manufacturing for AVERSA(TM) Fentanyl, a major milestone in the path to FDA approval
• Updated analyst report raises NTRB’s price target to $15.00 and reiterates an Outperform rating, citing favorable trial pathway and strong execution
• Aversa abuse-deterrent tech is protected by international patents and may address a global unmet need in safe pain management
• NTRB boosting their profile and credibility with its recent membership to the Russel Indexes

The opioid crisis remains one of the most pressing public health challenges of our time. While synthetic opioids like fentanyl play a crucial role in managing severe pain, their high abuse potential has led to a growing demand for smarter, safer delivery systems. As policymakers, healthcare providers, and regulators seek solutions that balance medical necessity with public safety, innovative technologies are emerging that could reshape how these powerful drugs are administered.

Nutriband and Kindeva Reach Key Manufacturing Milestone

One company aiming to bridge this gap is Nutriband (NASDAQ: NTRB). Recently, Nutriband announced it has completed commercial manufacturing process scale-up for its lead product, AVERSA(TM) Fentanyl, in partnership with global contract manufacturer Kindeva Drug Delivery. The achievement represents a critical step toward launching the world’s first abuse-deterrent transdermal fentanyl patch.

Aversa combines Nutriband’s proprietary abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch platform, and it is manufactured at Kindeva’s U.S.-based transdermal facility. With this milestone met, the company is now preparing to produce clinical supplies and submit an Investigational New Drug (“IND”) application to the FDA.

Unlike many traditional drug development pipelines, Aversa Fentanyl is positioned to follow the streamlined 505(b)(2) regulatory pathway, requiring only a single Phase 1 human abuse liability study prior to New Drug Application (“NDA”) submission. According to Noble Capital Markets, this study is low risk and designed to show that the Aversa patch is less attractive to potential abusers.

Analyst Coverage Reflects Confidence in Progress

Reflecting the growing confidence in Nutriband’s commercialization strategy, Noble Capital Markets has reiterated its Outperform rating on NTRB stock and raised its price target to $15.00, citing the company’s progress and efficient execution. The firm’s June 20, 2025, report notes that its prior projections accounted for a potential capital raise earlier in the year, which was ultimately not required, further improving earnings per share projections for FY2027.

The report highlights that AVERSA’s NDA is expected in late 2025 or early 2026, with full-year sales forecasted to begin in 2027. Notably, AVERSA Fentanyl is projected to reach peak U.S. annual sales of $80 to $200 million, depending on market penetration and adoption rates.

Intellectual Property and Global Potential

What makes Aversa especially noteworthy is its broad international patent portfolio, with protections granted in 46 countries, including the U.S., Europe, Japan, China, Canada, and Australia. The technology incorporates aversive agents into transdermal patches to deter abuse, misuse, and accidental exposure, common concerns in both hospital and home settings.

Although Nutriband is initially focused on U.S. approval and market entry, the company has clearly signaled its global ambitions, citing widespread unmet need for safer opioid delivery systems. The transdermal market offers a particularly compelling opportunity due to the ease of use and steady drug release profile of patch-based medications.

Kindeva Collaboration Offers Strategic Manufacturing Edge

Nutriband’s manufacturing partner, Kindeva, brings additional validation to the program. A leading CDMO with global reach, Kindeva offers advanced drug-device manufacturing capabilities, including aseptic fill-finish and sustainable inhalation propellants. By pairing Nutriband’s innovation with Kindeva’s manufacturing muscle, the partnership significantly reduces scale-up risk, a hurdle that has hampered many biopharma startups.

This strategic collaboration not only supports Aversa’s path to market but also sets the stage for future pipeline candidates utilizing the AVERSA platform across other transdermal opioids or CNS drugs.

A Timely Innovation for a Market in Need

As regulatory scrutiny on opioid safety continues to mount, Nutriband’s AVERSA(TM) Fentanyl is emerging as a potential game-changer in both pain management and public health. Its abuse-deterrent properties address core safety concerns without sacrificing therapeutic efficacy, a delicate balance that regulators and prescribers are actively seeking.

With clinical testing expected to begin soon and a regulatory path that’s both clear and efficient, Nutriband is well-positioned to transition from development-stage to commercial-stage in the next 18–24 months.

For Boosting their Investment Strategies

Nutriband was recently awarded with membership to the Russell Microcap, Russell Microcap Growth, Russell 3000E and Russell 3000E Growth Indexes, as part of the 2025 Russell indexes reconstitution. Investment managers and investors commonly use Russell indexes to construct index funds and as benchmarks for evaluating active investment strategies. Gareth Sheridan, CEO of Nutriband Inc. explained, “Being added to the four Russell indexes is a great honor for us as a company as we continue to strive towards building shareholder value and progressing the development of our AVERSA pipeline and in particular AVERSA Fentanyl which has the potential to reach peak annual US sales of $80 million to $200 million. We believe our addition now reflects a market focus on us as a company and the momentum we are building to revolutionize the safety profile of easily abused medications while making these medications available to those in need as a result,”

For more information, visit the company’s website at www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

• ESGold is celebrating the successful close of a private placement funding effort that will generate important financing for the company’s planned launch of a mine tailings cleanup and reclamation project later this year
• The financing drive was oversubscribed by more than 11%, which ESGold executives hail as evidence that investors like the company’s strategy for generating revenue 
• The company holds 265 mining claims on the historic Montauban mine site in Quebec, covering 13,116 hectares (about 32,410 acres) of gold and silver exploration
• ESGold expects to begin mill circuit production on the tailings cleanup later this year
• Mica recovered in the reclamation would be used in an innovative concentrate that is stronger than concrete and usable for construction materials such as bricks, parking columns, and highway Jersey barriers

ESGold (CSE: ESAU) (OTCQB: ESAUF), a pre-production gold and silver resource developer operating in Canada, has closed its recent non-brokered private placement funding effort after seeing a successful raise of $3,649,171 in aggregate gross proceeds to assist its pending processing of a site’s abandoned tailings. 

“This Offering was over-subscribed by more than 11% as a direct result of large investments by existing shareholders and new strategic investors who recognized that ESGold is focused and on track to production in the very near future,” ESGold CEO and Director Paul Mastantuono stated in a June 25 news release on the situation (https://ibn.fm/a3phQ).

ESGold is preparing to begin production later this year on a toxic tailings cleanup operation that will extract mica as well as any remaining gold and silver at the company’s mining claims on the historic Montauban mine site in Quebec, 80 kilometers (49.7 miles) west of the province’s capital city. The tailings cleanup effort is expected to generate significant asset value for shareholders through revenues derived from the cleanup operation, particularly by way of selling a concentrate that will be useful in building materials such as bricks, cinder blocks, paving stones, patio tiles, parking columns, and highway Jersey barriers.

ESGold has partnered with private consultancy DMCMS Inc., whose clean technology fuses mine waste with an organic polymer to create the concentrate, which is stronger than concrete. The cleanup will also allow ESGold to shine as the company fulfills its corporate sustainability goal of restoring mine sites back to a natural “green” state.

Production is expected to begin by year-end, and the private placement raise will be used for the construction of the mill circuit and related assembly, as well as needs for final mobilization of the project and general working capital requirements, according to the company. 

As revenues are generated by the gold, silver, and mica recovered from the tailings cleanup, the company will begin working to reinvest it in new district scale exploration potential at the Montauban mine site. 

The company’s strategic plan has proved popular with existing investors, including key stakeholders as well as New York-based hedge funds and family offices. “Their ongoing participation highlights the growing institutional confidence in ESGold’s clean production model and its near-term exploration potential,” a June 23 news release adds (https://ibn.fm/7f9Fr).

“We have the capacity to generate on our first four, five years, close to $350 million on this low-hanging fruit (the tailings mineral cleanup and reuse), with almost zero (additional) cost,” Mastantuono said during an interview with the Exploring Mining Podcast that highlighted the company’s excitement for its successful ramp-up thus far (https://ibn.fm/a5sUH).

For more information, visit the company’s website at https://esgold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

• The company announced its expansion into the $395 billion global data center market as a developer, owner, and strategic partner.
• The move underscores SolarBank’s commitment to integrating renewable energy in diverse, emerging sectors.
• AI data centers are projected to need 30 times more power by 2035, creating a critical opportunity for clean energy solutions.
• The company joins tech giants and specialized data center providers focused on sustainability and resilience in digital infrastructure.

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., continues its focus on  the rapidly growing data center sector, highlighting its plan to serve as a developer, owner, and partner in one of the world’s fastest-expanding infrastructure markets. This focus comes as the global data center industry is forecast to reach $395 billion by 2030, fueled by explosive demand for cloud computing, big data, and artificial intelligence technologies (https://ibn.fm/8SI6a).

SolarBank’s focus arrives at a pivotal time for the sector. According to Deloitte, the power consumption of AI data centers could jump from 4 gigawatts today to 123 gigawatts by 2035, a thirtyfold increase that will stretch existing power grids and infrastructure (https://ibn.fm/bFoCC). The scale of that growth underscores a crucial challenge: meeting enormous power demands while maintaining environmental responsibility.

Richard Lu, CEO of SolarBank, described the expansion as a natural progression of the company’s mission (https://ibn.fm/ohBpQ). “Our experience in renewable energy will enable us to deliver energy-efficient, carbon-reducing data centers to support today’s data needs and tomorrow’s technological advancements,” Lu said.

The stakes are high. Deloitte warns that while data centers can be built relatively quickly, delays in power infrastructure, including long lead times for new gas plants and seven-year waits for grid connections, risk bottlenecking AI growth. Simultaneously, the data center sector faces skilled labor shortages, supply chain challenges, and increasingly strict environmental regulations, complicating timelines for construction and permitting.

Amid these headwinds, SolarBank is positioning its renewable energy expertise as a potential solution. The company intends to build partnerships in energy-efficient, low-carbon data center infrastructure, addressing the industry’s carbon footprint and helping data centers meet their sustainability targets. SolarBank’s move parallels efforts by Amazon, Google, and Microsoft, which have poured billions into ensuring their data centers align with climate goals.

In fact, large tech companies and specialized data center operators, from Meta Platforms to Equinix and Digital Realty, have collectively invested over $100 billion in new facilities over the past five years. Like SolarBank, these firms see sustainability as a critical differentiator as they navigate rising power demands and public pressure to decarbonize.

SolarBank is expanding into the data center industry, but does not currently have any data center projects under development nor any for which it has secured rights. SolarBank does not have any contracts with the parties mentioned in this report. It is in discussions with various other parties regarding potential data center opportunities and will provide details in a future news release if an agreement to acquire or develop a data center is concluded.

As SolarBank broadens its reach, it is exploring strategic partnerships with existing data center developers and infrastructure specialists. The company aims to create solutions that are scalable, resilient, and future-focused, offering not only power capacity but also lower carbon intensity in an industry often criticized for its heavy energy consumption.

As Lu noted, “Expanding into the data center business aligns with our vision of creating a resilient and sustainable energy grid.” That vision appears increasingly relevant as the global economy grows more dependent on digital infrastructure and the electricity to power it.

SolarBank’s foray into data centers underscores its commitment to integrating renewables across emerging and diverse markets, tapping into a powerful trend of decarbonization in mission-critical infrastructure. “As the world accelerates toward a future driven by AI, automation, and clean energy, SolarBank remains committed to delivering innovative, scalable solutions that not only power industries but also empower communities,” Lu concluded.

For more information, visit the company’s website at SolarBankCorp.com.

This report contains forward looking information. Please refer to the press release entitled “SolarBank Expands into the projected $395 Billion Data Center Market as Developer and Strategic Partner” for additional details.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

Australia occupies a top-tier position among the world’s industrial drivers for mining interests, particularly when it comes to the fuel sector’s production and trade of gas and coal. The country is also a leading producer of iron ore, nickel, aluminum, copper, gold, silver, and lithium, among other precious resources (https://ibn.fm/BrmFY).

Western Australia is a significant hub for the country’s mining activity, and it’s there that global resource media services provider Aspermont has established the premier Future of Mining Australia 2025 event scheduled to take place next month.

Experts and dignitaries from across the globe will join other thought leaders in presenting data and insights on the future of global mining, trade supply challenges and technological resource development during the July 1-2 conference. Among the more than 100 speakers appearing on five stages will be the ambassadors of Mongolia, Peru and Indonesia, as well as government officials from Oman, Nigeria and Timor-Leste. The multitude of companies represented include global industry leaders Rio Tinto, BHP and Glencore.

The agenda includes: 

• Two days of insights from speakers on Australia’s mining opportunities, with solution-driven discussions on electrification, tariffs and regulation.
• Future-mapping presentations on industry risk, changing investor sentiment, environmental and social (“ESG”) initiatives, and value chain strategies.
• Networking opportunities with peers and thought leaders.
• Technological resource strategy and implementation insights.
• Regulatory and resource policy direction from various government leaders.
• Training, health and recruitment ideas for company leaders.
• Workshops with case studies and breakthrough empowerment.

The Future of Mining Australia is focused on moving forward purposefully and with resilience toward the zero entry, zero harm, and zero emission mine, according to the host. The conference values live, in-person interaction, that helps attendees develop competitively, access the latest technology, and assess market intelligence while creating their own roadmap for success and gaining actionable outcomes.

Exhibitions at the conference will include AR and VR technologies, robotics, wearables and machine automation.

Attendees will also have the benefit of enjoying the Crown Perth’s resort hotel and casino complex situated along Perth’s Swan River, about 15 minutes from the airport. Perth is one of the country’s largest cities, the capital of Western Australia, and the business district is steeped in history as the area of the original British settlements that will celebrate a bicentennial later this decade.

The two-day conference coincides with Aspermont’s Mining News Select Australia conference, which is also expected to gather a wide number of attendees involved in the mining industry, with concierge hosted meetings for interested investors focused on exploring the potential that companies at the conference represent.

For more information and to register for the Future of Mining Australia 2025 event, visit https://ibn.fm/g5CTi.

• ESGold CEO and Director Paul Mastantuono recently appeared on the Exploring Mining Podcast to discuss the company’s reuse and discovery plans for the historic Montauban gold and silver mine site in Canada, west of Quebec City
• ESGold is sidestepping the traditional junior miner model of obtaining investor financing for mine development, focusing instead on building revenues through tailings cleanup and repurposing that can then be reinvested in mining operations
• The gold and silver resource developer is focused on an environmental and social governance mission that would minimize pollutants while repurposing waste minerals for useful construction products
• The company’s operation in Quebec is fully permitted and expects to begin production this year

Production is expected to begin by year end on a tailings cleanup operation by precious metal resource developer ESGold (CSE: ESAU) (OTCQB: ESAUF). The process will provide for the economically and environmentally friendly reuse of mineral resources at the Montauban mine in Quebec where new gold and silver discovery is expected, company CEO and Director Paul Mastantuono told the Exploring Mining Podcast recently. 

“Even right now with values, gold (at its) current prices, that low-hanging fruit — (recovering) surface material, tailings, … 400,000 metric tons — we have the capacity to generate on our first four, five years, close to $350 million on this low-hanging fruit, with almost zero cost,” Mastantuono said of the company’s reuse-first strategy (https://ibn.fm/WMXKM).

“(And then we would) be able to take that money and invest it and build real value going into the ground,” he added in regard to the plans for later mining of precious metals. “That was our whole focus, just keep things very simple.”

ESGold holds 265 mining claims on the historic Montauban mine site in Quebec, covering 13,116 hectares (about 32,410 acres) of abandoned gold and silver exploration 80 kilometers (49.7 miles) west of the province’s capital city. 

Mastantuono’s comments in the podcast addressed the company’s strategic shift toward focusing on high-value, low-cost resources like tailings and surface ore bodies as a means of delivering shareholder value by moving away from the traditional drilling-heavy model of junior mining (https://ibn.fm/FxSin).

“(It’s) focusing on simplified solutions and keeping on track with what is the simplest way to generate cash flow,” he said. “We’re able to create a concentrate, and if we’ll be able to get that concentrate high enough, then we’re able to literally pour the concentrate directly into a wabi furnace that we have on site and literally pour doré bars very, very quickly.”

ESGold’s heavy emphasis on building a profitable metals market model from ESG (environmental, social, and governance) values will rely on gravity separation in a Humphrey spiral concentrator to recover mica, gold and silver from the tailings without having to use the cyanide polluting extraction methods employed by other recovery operations. 

The recovered mica concentrate will be used to create a stronger-than-concrete material for products such as bricks, cinder blocks, paving stones, patio tiles, parking columns and highway Jersey barriers, based on a clean technology developed by partner DMCMS Inc.

The company plans to begin processing the tailings within the next six months, Mastantuono said, potentially by the end of October. Testing of the Humphrey spiral concentrator this month has been under way to establish whether production will be able to speed up with the pouring of doré bars directly onsite. 

For more information, visit the company’s website at https://esgold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

• The company has completed its acquisition of a 52% controlling stake in Italian Serie B club SS Juve Stabia.
• The club’s valuation rose from $9.3 million to $32.3 million over the 2024–25 season.
• Juve Stabia reached the semifinals of the Serie A promotion playoffs, boosting its market value.
• Brera’s multi-club ownership strategy aims to drive operational efficiencies and shareholder value.
• The acquisition highlights Brera’s ambition to expand its portfolio through strategic investments in promising clubs.

Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) strategy, has completed the final closing of its 52% majority ownership stake in SS Juve Stabia srl, marking a milestone in its growing international sports portfolio. The deal, finalized on June 20, 2025, follows a multistep process that began in December 2024, when Brera agreed to acquire a controlling interest from the club’s prior majority owner, XX Settembre srl, led by club President Andrea Langella (https://ibn.fm/j6Wi9).

The acquisition comes at a time of remarkable growth for Juve Stabia, whose squad value increased 245% during the 2024–25 season, rising from $9.3 million to $32.3 million (https://ibn.fm/BnVIt). According to analysis from Transfermarkt and Social Media Soccer, published in Virgilio Sport, Juve Stabia recorded the highest market value growth in Italy’s Serie B (https://ibn.fm/xMvK7).

On the pitch, Juve Stabia posted a strong campaign, advancing from fifth place in the regular season to reach the semifinals of the Serie A promotion playoffs. That competitive success helped drive significant gains in the club’s overall valuation, reflecting both improved player performance and increased fan engagement.

Brera’s management team pointed to these results as proof of its investment thesis. “This extraordinary growth reflects both the untapped potential of Juve Stabia and Brera’s value-creation strategy in action,” said Daniel McClory, Executive Chairman of Brera Holdings. He noted that Brera’s approach, centered on operational alignment, player development, and shareholder value creation, is already showing positive results and positions the company for future expansion.

The deal also underscores Brera’s ambition to scale its multi-club ownership model by acquiring promising teams with a clear growth trajectory. Juve Stabia’s history and loyal fan base, along with its recent rise in Serie B, offer a strong platform for Brera to build on. McClory highlighted plans to collaborate closely with Andrea Langella and the club’s existing management, aiming to develop young talent and potentially challenge for Serie A promotion again in the coming seasons. “This investment reflects our confidence in Juve Stabia’s potential to deliver robust contributions to Brera Holdings and our shareholders in 2025 and beyond,” he added.

Regulatory approval from the Italian football governing body, FIGC, further supports Brera’s push for institutional excellence and transparent governance as a Nasdaq-listed firm. That endorsement could ease the path for Brera to pursue additional European acquisitions under its multi-club strategy.

Juve Stabia, known as “The Second Team of Naples,” is a respected name in Italian football, and its recent surge in value demonstrates the financial potential of even mid-tier clubs when combined with sound strategic planning. The broader goal is to integrate Juve Stabia into a portfolio of men’s and women’s teams that can share resources, best practices, and commercial opportunities. That approach reflects a trend across global sports ownership, where portfolio operators seek synergies in branding, talent pipelines, and sponsorship to drive long-term growth.

For more information, visit the company’s website at www.BreraHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to BREA are available in the company’s newsroom at https://ibn.fm/BREA

• Adageis, a company offering a powerful and patented AI-centric software solution, remains committed to streamlining the healthcare sector, making it easier for providers to meet their financial goals
• It works with over 90 Electronic Health Record platforms, an unrivalled level of access that gives its users actionable insights at the point of care
• The company covers over 260,000 patient lives, and looks to double that to 580,000, achieving its $100,000 monthly recurring revenue target

Adageis, a company offering powerful and patented AI-based software, provides flexible healthcare and related software solutions for providers and healthcare systems. The company remains committed to streamlining these structures while helping practices turn improved care quality into positive financial outcomes. Its commitment to the industry ensures that it advocates for its clients, not just by revealing and simplifying integral information that is key to decision-making, but also by working directly with insurance payers on behalf of providers, allowing them to better navigate negotiations and understand their entitlements.

With Adageis, healthcare providers can more clearly see how their clinical decisions shape their revenue. System users can gain unrivalled clarity in dealing with complex healthcare systems, enabling physicians and administrators to identify which of their services yield the highest value. This eliminates the need for outside consultants, allowing for faster decision-making and iterations that not only improve the quality of patient care but also enhance financial earnings.

Today, Adageis works with over 90 Electronic Health Record platforms, including Greenway Health, eClinicalWorks, AdvancedMD, and American Medical Software, among others. This unrivalled level of access enables the company to provide its users with actionable insights at the point of care. The system has been lauded for its utility, transforming entire organizations from reactive to proactive, making it easier for them to meet their quality metrics (https://ibn.fm/n7Iyb).

“Healthcare is a complicated place, and navigating the system is extremely difficult for patients,” noted Adageis’ CEO, Shane Speirs. “What Adageis does is provide a simple solution to healthcare organizations, ranging from large, multi-state, multi-specialty healthcare groups to independent practices across the country. We offer a solution that meets everyone’s needs, helping providers and organizations drive revenue by delivering high-quality care, which everyone can align with,” he added (https://ibn.fm/QcGyo).

Adageis already covers over 260,000 patient lives. By the start of Q3, it expects to double that figure to 580,000, realizing its $100,000 monthly recurring revenue target, while continually improving its product (https://ibn.fm/fJdBU).

Adageis directly addresses the growing complexities and challenges in the healthcare marketplace. It does this by integrating different electronic health record systems and overlaying existing platforms to provide easy-to-read measures “tailored to each patient’s insurance.” This differentiator, experts say, sets Adageis apart from its peers and has been driving its steady growth.

For company information, visit the company’s website at www.Adageis.com.

NOTE TO INVESTORS: The latest news and updates relating to Adageis are available in the company’s newsroom at https://ibn.fm/Adageis

• A focus during the webinar was the investigator-initiated study currently being conducted at the University of Pennsylvania under the leadership of Dr. Ellen Kim.
• Interim results show that among the first eight patients who completed 18 weeks of treatment, 75% demonstrated a greater than 50% reduction in disease severity.
• Soligenix anticipates top-line results from the phase 3 trial in the second half of 2026.

In a recent webinar hosted by Allele Capital, Soligenix (NASDAQ: SNGX) executives Dr. Christopher Schaber and Dr. Christopher Pullion shared detailed updates on the company’s HyBryte(TM) (synthetic hypericin) clinical development (https://ibn.fm/dz7eO). The event offered an in-depth look at Soligenix’s ongoing confirmatory phase 3 trial for cutaneous T-cell lymphoma (“CTCL”), a rare non-Hodgkin’s lymphoma, and discussed promising data emerging from an investigator-initiated study conducted at the University of Pennsylvania. Soligenix, a late-stage biopharmaceutical company, is dedicated to developing and commercializing treatments for rare diseases and unmet medical needs, and HyBryte(TM) represents the company’s lead asset aimed at transforming the treatment landscape for CTCL.

HyBryte(TM) is a topical therapy activated by visible light that is applied directly to cancerous lesions on the skin, primarily targeting early-stage mycosis fungoides, which account for nearly 90% of CTCL cases. According to Dr. Schaber, Soligenix chairman, president and CEO, CTCL affects approximately 40,000 patients worldwide and is considered a chronic, relapsing disease that currently lacks an approved front-line treatment. HyBryte(TM) has the potential to fill that void, representing a significant commercial and therapeutic opportunity, with Soligenix estimating a market potential of more than $250 million globally and approximately $100 million in peak U.S. sales.

A central focus of the webinar was the investigator-initiated study currently being conducted at the University of Pennsylvania under the leadership of Dr. Ellen Kim, a recognized expert in CTCL and the lead principal investigator for both the original FLASH study and the ongoing phase 3 confirmatory FLASH2 trial. The study was designed to simulate real-world conditions by administering HyBryte(TM) twice weekly for up to one year, without treatment breaks, until patients reached disease clearance or a one-year mark. Using the Composite Assessment of Index Lesion Severity (“CAILS”) scoring system — a validated clinical tool and the gold standard in CTCL trials — researchers evaluated changes in lesion severity and response to treatment.

Interim results from the study were encouraging, reported Dr. Pullion, Soligenix medical director and CTCL program lead. Among the first eight patients who completed 18 weeks of treatment, 75% (six patients) demonstrated a greater than 50% reduction in disease severity, meeting the defined treatment response threshold. Moreover, 85% of patients across the study achieved similar reductions over time, and three patients reached complete remission with no visible lesions remaining. Importantly, the therapy exhibited an excellent safety profile with no serious adverse events, and participants showed strong compliance, further highlighting HyBryte(TM)’s potential as a well-tolerated, effective treatment for long-term disease management.

The findings from the study are particularly significant because of their close alignment with the ongoing phase 3 confirmatory FLASH2 trial. As Dr. Pullion explained, the phase 3 trial mirrors the treatment regimen used in the University of Pennsylvania study: the same dosage, the same scoring system and the same patient population. The primary endpoint in the phase 3 study is also measured at 18 weeks, the same time frame at which the earlier study showed strong results. Given the consistent methodology and encouraging parallels, Dr. Pullion expressed cautious optimism that the phase 3 trial will replicate the positive outcomes of earlier clinical trials and the investigator-initiated study.

Further comparisons between the clinical trials were outlined during the webinar. The original FLASH trial was the largest multicenter, double-blind, placebo-controlled study conducted for CTCL, and it met its primary endpoint of lesion improvement after treatment cycles that included treatment pauses. In contrast, the confirmatory phase 3 FLASH2 trial is designed to provide continuous therapy without breaks or pauses, which is expected to enhance efficacy, based on lessons learned from earlier trials. The current trial also benefits from participation by leading centers of excellence who are familiar with the therapy and motivated by the pressing need for new CTCL treatments.

Dr. Pullion emphasized that HyBryte(TM)’s ability to treat both patch and plaque lesions, often challenging for other topical therapies, is a major differentiator. Unlike some existing chemotherapeutic topical treatments that cause skin irritation or systemic side effects, HyBryte(TM) has shown minimal systemic absorption and a benign side effect profile. This positions it as a particularly attractive first-line option for CTCL patients, who often face lifelong treatment regimens and need therapies that are not only effective but also safe and tolerable over time.

As for what’s next, Schaber shared that Soligenix anticipates top-line results from the phase 3 FLASH2 trial in the second half of 2026. Meanwhile, an update on enrollment progress is expected later in 2025, with current trends suggesting enrollment is on track and may even be ahead of initial expectations. With data from the initial FLASH trial already published in JAMA Dermatology and the investigator-initiated study reinforcing the positive results, the company is entering a pivotal stage in development.

The webinar closed with both SNGX executives reiterating their commitment to addressing the critical unmet needs in CTCL. By building upon over a decade of research, clinical engagement and patient advocacy, Soligenix is positioning HyBryte(TM) not just as a novel therapeutic agent, but as a potential paradigm-shifting front-line treatment in the CTCL landscape.

For more information, visit www.Soligenix.com.

NOTE TO INVESTORS: The latest news and updates relating to SNGX are available in the company’s newsroom at https://ibn.fm/SNGX

• Total indicated underground mineral resources of 3.17 million tonnes at Camp and Los Cuyes deposits, containing 0.37 million gold equivalent ounces at a cutoff grade of 2.2 g/t AuEq.
• Total inferred underground mineral resources of 12.1 Mt at Camp and Los Cuyes deposits, containing 1.50 million gold equivalent ounces at a cutoff grade of 2.2 g/t AuEq. Ongoing 3,500-metre drill program set to expand known mineralization zones.
• Preliminary Economic Assessment for underground operation expected by year-end 2025.
• El Domo Project development on track with detailed cost breakdown and construction timeline targeting 2026 production.

Silvercorp Metals (NYSE-A: SVM) (TSX: SVM), a Canadian mining company producing silver, gold, lead, and zinc with a long history of profitability, has announced an updated mineral resource estimate (“MRE”) for its Condor Project, located in Ecuador’s Zamora-Chinchipe Province.

The new estimate, effective as of Feb. 28, 2025, was prepared by SRK Consulting (Canada) Inc., in accordance with National Instrument 43-101 standards, and marks the first step in Silvercorp’s effort to reposition Condor as a high-grade underground gold project (https://ibn.fm/J4HYK). An updated Preliminary Economic Assessment (“PEA”) is expected later this year. The project was previously envisioned as a low-grade, bulk-tonnage open pit, which would have been costly to develop and challenging to permit.

The update centers on the Camp and Los Cuyes deposits. At a cut-off grade of 2.2 g/t AuEq, indicated resources included 3.17 million tonnes at an average grade of 3.58 g/t AuEq, totaling 0.37 million ounces. Additionally, inferred resources included 12.1 million tonnes grading 3.84 g/t AuEq, totalling 1.50 million ounces AuEq.

Metallurgical testing yielded favorable gold recoveries: up to 96% at Camp and 88% at Los Cuyes based on cyanide leaching.

Although the underground strategy dominates the current outlook, Silvercorp also reported open-pit constrained resources at the Soledad and Enma deposits. These include 0.15 million ounces AuEq in the indicated category and 0.38 million in the inferred category, at cut-off grades of 0.5 g/t for Soledad and 0.6 g/t for Enma.

The Condor Project is located in a volcanic complex that intrudes older granodiorite rocks, where gold and silver mineralization is consistent with a low to intermediate sulphidation epithermal system. Mineralization styles vary across the deposits, including sub-vertical sulfide-bearing veins and wider zones of disseminated mineralization.

Gold is primarily associated with pyrite and sphalerite, with smaller amounts of galena and chalcopyrite. These characteristics shape the company’s ongoing exploration targets and development scenarios.

To advance the project, Silvercorp has launched a 3,500-metre (10 holes) surface drilling campaign in May 2025, testing areas where the company sees exploration potential. Drilling will focus on:

• Broad zones of sub-horizontal disseminated gold mineralization in rhyolitic tuffs at Los Cuyes.
• Contact zones between rhyolite domes and batholith granodiorite at Camp for wide mineralization.
• Gap areas between Camp, Soledad, Los Cuyes, and Enma deposits, testing for potential connection and strike extension of mineralized structures.

In parallel, Silvercorp is advancing a PEA for an underground operation at Condor, expected by the end of 2025. The company is also working to secure the permits and community agreements required to develop underground exploration tunnels which it is planning to build in 2H 2026.

The Condor update follows Silvercorp’s recent construction budget announcement for the El Domo Project, also in Ecuador. The company expects to bring El Domo into production by the end of 2026 at a revised cost of $240.5 million, below the 2021 feasibility estimate of $247.6 million (https://ibn.fm/bd01V).

The development has been divided into several stages, each with its own budget and timeline:

• Package #1: Site Preparation and Infrastructure – $47.5 million: Earthworks began earlier this year, with full site readiness targeted by Q4 2025.
• Package #2: Open Pit Mining and Stripping – $39 million: This stage will begin in August 2025. It involves producing 43,000 tonnes of ore by end-2026 and creating a ready-to-mine inventory of 550,000 cubic metres of ore to support three years of production.
• Package #3: Processing Plant and Equipment – $33 million: Engineering and equipment selection is being led by China’s Jinpeng Group, with construction slated to begin in September 2025.

Additionally, Silvercorp has signed a power line agreement with Ecuador’s state utility CNEL EP. Construction is set to begin in the summer of 2025, with an estimated completion time of 13–17 months. Final costs and contractor selections are still pending. In response to Ecuador’s seasonal power supply instability, Silvercorp has sourced diesel power generators to provide backup electricity. These will be operational before the process plant comes online.

Silvercorp’s ongoing investment in Ecuador reflects its long-term strategy to generate shareholder value through high-quality assets, free cash flow from established operations, and disciplined project development. With a portfolio that includes multiple projects in Ecuador and China, the company has an 18-year track record of profitability and remains focused on ensuring organic growth through extensive drilling for discovery; ongoing merger and acquisition efforts; and an unwavering commitment to responsible mining and ESG.

For more information, visit the company’s website at www.silvercorpmetals.com/welcome.

Third-Party Content Disclaimer

The IBN website may contain third-party content articles and other content submitted by third parties, including articles submitted through the IBN Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of IBN or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and IBN does not endorse, guarantee or make representations concerning the accuracy and completeness of any third-party content. You acknowledge that by IBN providing you with this internet portal that makes accessible to you the ability to view third party content through the IBN site, IBN does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. IBN expressly disclaims liability relating to such third-party content. IBN and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, IBN reserves the right to remove third-party content at any time in its sole discretion. By viewing this third-party content, you acknowledge that you have viewed, read fully, accepted and agreed to all terms of the Disclaimer at https://IBN.fm/Disclaimer.